Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
Identifieur interne : 001957 ( Main/Curation ); précédent : 001956; suivant : 001958Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
Auteurs : Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Carl Counsell [Portugal] ; Nir Giladi [Israël] ; Robert G. Holloway [États-Unis] ; Charity G. Moore [États-Unis] ; Gregor K. Wenning [Autriche] ; Melvin D. Yahr [États-Unis] ; Lisa Seidl [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2004-09.
English descriptors
Abstract
The Movement Disorder Society Task Force for Rating Scales for Parkinson's disease (PD) prepared a critique of the Hoehn and Yahr scale (HY). Strengths of the HY scale include its wide utilization and acceptance. Progressively higher stages correlate with neuroimaging studies of dopaminergic loss, and high correlations exist between the HY scale and some standardized scales of motor impairment, disability, and quality of life. Weaknesses include the scale's mixing of impairment and disability and its non‐linearity. Because the HY scale is weighted heavily toward postural instability as the primary index of disease severity, it does not capture completely impairments or disability from other motor features of PD and gives no information on nonmotor problems. Direct clinimetric testing of the HY scale has been very limited, but the scale fulfills at least some criteria for reliability and validity, especially for the midranges of the scale (Stages 2–4). Although a “modified HY scale” that includes 0.5 increments has been adopted widely, no clinimetric data are available on this adaptation. The Task Force recommends that: (1) the HY scale be used in its original form for demographic presentation of patient groups; (2) when the HY scale is used for group description, medians and ranges should be reported and analysis of changes should use nonparametric methods; (3) in research settings, the HY scale is useful primarily for defining inclusion/exclusion criteria; (4) to retain simplicity, clinicians should “rate what you see” and therefore incorporate comorbidities when assigning a HY stage; and (5) because of the wide usage of the modified HY scale with 0.5 increments, this adaptation warrants clinimetric testing. Without such testing, however, the original five‐point scales should be maintained. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.20213
Links toward previous steps (curation, corpus...)
- to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001C28
Links to Exploration step
ISTEX:25C8B049203E387D2A310E570388B735CA99635ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease</title>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
<affiliation wicri:level="2"><mods:affiliation>Rush University Medical Center, Chicago, IL</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Rush University Medical Center, Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation wicri:level="1"><mods:affiliation>Innsbruck University Hospital, Innsbruck, Austria</mods:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Innsbruck University Hospital, Innsbruck</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation wicri:level="1"><mods:affiliation>Rascol, Laboratoire de Pharmacologie Medicale et Clinique, Toulouse, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Rascol, Laboratoire de Pharmacologie Medicale et Clinique, Toulouse</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
<affiliation wicri:level="1"><mods:affiliation>University of Aberdeen, Aberdeen, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Aberdeen, Aberdeen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name>
<affiliation wicri:level="2"><mods:affiliation>Rush University Medical Center, Chicago, IL</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Rush University Medical Center, Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Counsell, Carl" sort="Counsell, Carl" uniqKey="Counsell C" first="Carl" last="Counsell">Carl Counsell</name>
<affiliation wicri:level="1"><mods:affiliation>Hospital de Santa Maria, Lisbon, Portugal</mods:affiliation>
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Hospital de Santa Maria, Lisbon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Giladi, Nir" sort="Giladi, Nir" uniqKey="Giladi N" first="Nir" last="Giladi">Nir Giladi</name>
<affiliation wicri:level="1"><mods:affiliation>Tel Aviv Sourasky Medical Center, Tel‐Aviv, Israel</mods:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Tel Aviv Sourasky Medical Center, Tel‐Aviv</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Holloway, Robert G" sort="Holloway, Robert G" uniqKey="Holloway R" first="Robert G." last="Holloway">Robert G. Holloway</name>
<affiliation wicri:level="2"><mods:affiliation>University of Rochester Medical Center, Rochester, NY</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>University of Rochester Medical Center, Rochester</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Moore, Charity G" sort="Moore, Charity G" uniqKey="Moore C" first="Charity G." last="Moore">Charity G. Moore</name>
<affiliation wicri:level="2"><mods:affiliation>University of South Carolina, Columbia, SC</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Sud</region>
</placeName>
<wicri:cityArea>University of South Carolina, Columbia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K." last="Wenning">Gregor K. Wenning</name>
<affiliation wicri:level="1"><mods:affiliation>Innsbruck University Hospital, Innsbruck, Austria</mods:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Innsbruck University Hospital, Innsbruck</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yahr, Melvin D" sort="Yahr, Melvin D" uniqKey="Yahr M" first="Melvin D." last="Yahr">Melvin D. Yahr</name>
<affiliation wicri:level="2"><mods:affiliation>Mount Sinai Medical Center, New York, NY</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Mount Sinai Medical Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Seidl, Lisa" sort="Seidl, Lisa" uniqKey="Seidl L" first="Lisa" last="Seidl">Lisa Seidl</name>
<affiliation wicri:level="2"><mods:affiliation>The Movement Disorder Society, Milwaukee, WI</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Wisconsin</region>
</placeName>
<wicri:cityArea>The Movement Disorder Society, Milwaukee</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:25C8B049203E387D2A310E570388B735CA99635E</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.20213</idno>
<idno type="url">https://api.istex.fr/document/25C8B049203E387D2A310E570388B735CA99635E/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001C28</idno>
<idno type="wicri:Area/Main/Curation">001957</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease</title>
<author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name>
<affiliation wicri:level="2"><mods:affiliation>Rush University Medical Center, Chicago, IL</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Rush University Medical Center, Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation wicri:level="1"><mods:affiliation>Innsbruck University Hospital, Innsbruck, Austria</mods:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Innsbruck University Hospital, Innsbruck</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation wicri:level="1"><mods:affiliation>Rascol, Laboratoire de Pharmacologie Medicale et Clinique, Toulouse, France</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Rascol, Laboratoire de Pharmacologie Medicale et Clinique, Toulouse</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
<affiliation wicri:level="1"><mods:affiliation>University of Aberdeen, Aberdeen, United Kingdom</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Aberdeen, Aberdeen</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name>
<affiliation wicri:level="2"><mods:affiliation>Rush University Medical Center, Chicago, IL</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Rush University Medical Center, Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Counsell, Carl" sort="Counsell, Carl" uniqKey="Counsell C" first="Carl" last="Counsell">Carl Counsell</name>
<affiliation wicri:level="1"><mods:affiliation>Hospital de Santa Maria, Lisbon, Portugal</mods:affiliation>
<country xml:lang="fr">Portugal</country>
<wicri:regionArea>Hospital de Santa Maria, Lisbon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Giladi, Nir" sort="Giladi, Nir" uniqKey="Giladi N" first="Nir" last="Giladi">Nir Giladi</name>
<affiliation wicri:level="1"><mods:affiliation>Tel Aviv Sourasky Medical Center, Tel‐Aviv, Israel</mods:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Tel Aviv Sourasky Medical Center, Tel‐Aviv</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Holloway, Robert G" sort="Holloway, Robert G" uniqKey="Holloway R" first="Robert G." last="Holloway">Robert G. Holloway</name>
<affiliation wicri:level="2"><mods:affiliation>University of Rochester Medical Center, Rochester, NY</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>University of Rochester Medical Center, Rochester</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Moore, Charity G" sort="Moore, Charity G" uniqKey="Moore C" first="Charity G." last="Moore">Charity G. Moore</name>
<affiliation wicri:level="2"><mods:affiliation>University of South Carolina, Columbia, SC</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Sud</region>
</placeName>
<wicri:cityArea>University of South Carolina, Columbia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Wenning, Gregor K" sort="Wenning, Gregor K" uniqKey="Wenning G" first="Gregor K." last="Wenning">Gregor K. Wenning</name>
<affiliation wicri:level="1"><mods:affiliation>Innsbruck University Hospital, Innsbruck, Austria</mods:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Innsbruck University Hospital, Innsbruck</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yahr, Melvin D" sort="Yahr, Melvin D" uniqKey="Yahr M" first="Melvin D." last="Yahr">Melvin D. Yahr</name>
<affiliation wicri:level="2"><mods:affiliation>Mount Sinai Medical Center, New York, NY</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Mount Sinai Medical Center, New York</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Seidl, Lisa" sort="Seidl, Lisa" uniqKey="Seidl L" first="Lisa" last="Seidl">Lisa Seidl</name>
<affiliation wicri:level="2"><mods:affiliation>The Movement Disorder Society, Milwaukee, WI</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Wisconsin</region>
</placeName>
<wicri:cityArea>The Movement Disorder Society, Milwaukee</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-09">2004-09</date>
<biblScope unit="volume">19</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="1020">1020</biblScope>
<biblScope unit="page" to="1028">1028</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">25C8B049203E387D2A310E570388B735CA99635E</idno>
<idno type="DOI">10.1002/mds.20213</idno>
<idno type="ArticleID">MDS20213</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Hoehn and Yahr scale</term>
<term>Parkinson's disease</term>
<term>clinimetrics</term>
<term>rating scales</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Movement Disorder Society Task Force for Rating Scales for Parkinson's disease (PD) prepared a critique of the Hoehn and Yahr scale (HY). Strengths of the HY scale include its wide utilization and acceptance. Progressively higher stages correlate with neuroimaging studies of dopaminergic loss, and high correlations exist between the HY scale and some standardized scales of motor impairment, disability, and quality of life. Weaknesses include the scale's mixing of impairment and disability and its non‐linearity. Because the HY scale is weighted heavily toward postural instability as the primary index of disease severity, it does not capture completely impairments or disability from other motor features of PD and gives no information on nonmotor problems. Direct clinimetric testing of the HY scale has been very limited, but the scale fulfills at least some criteria for reliability and validity, especially for the midranges of the scale (Stages 2–4). Although a “modified HY scale” that includes 0.5 increments has been adopted widely, no clinimetric data are available on this adaptation. The Task Force recommends that: (1) the HY scale be used in its original form for demographic presentation of patient groups; (2) when the HY scale is used for group description, medians and ranges should be reported and analysis of changes should use nonparametric methods; (3) in research settings, the HY scale is useful primarily for defining inclusion/exclusion criteria; (4) to retain simplicity, clinicians should “rate what you see” and therefore incorporate comorbidities when assigning a HY stage; and (5) because of the wide usage of the modified HY scale with 0.5 increments, this adaptation warrants clinimetric testing. Without such testing, however, the original five‐point scales should be maintained. © 2004 Movement Disorder Society</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001957 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001957 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonV1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:25C8B049203E387D2A310E570388B735CA99635E |texte= Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |